Robot-assisted Walking Treatment in Hereditary Spastic Paraplegia (HSP)

Condition(s) studied

Investigational drug(s) / intervention(s)

Robot-Assisted Gait Training: 15 sessions of robot-assisted gait training(LOKOMAT)+ 15 session of usual treatment for a total of 30 sessions in three weeks. 45 minutes for each session.

Study summary

Patients will undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. Two sessions/day for 5 days a week. The same subjects will conduct clinical-functional assessments before, at the end of treatment, and after a 3-month follow-up:

3D Gait Analysis with defined protocol (BTSBioenginner); Spastic Paraplegia Rating Scale (SPRS); Six-Minute Walk Test (6MWT), Ten Meters Walk Test (10MWT), Gross Motor Function Measure-88 (GMFM-88) and Berg Balance Scale (BBS); Quality of life questionnaires: Medical Outcome Survey Short Form (SF-36) and ad hoc questionnaire for subjective assessment of symptoms during walking (HSP-SNAP).

This study is part of normal clinical practice and does not involve any changes to the current rehabilitation course for patients.

Eligibility

Primary outcome measure(s)

• Six-Minute Walk Test (6MWT) — T0(pre-training)
  Endurance Test
• Six-Minute Walk Test (6MWT) — T1(after 3 weeks of training)
  Endurance Test
• Six-Minute Walk Test (6MWT) — T2(3 months after T1)
  Endurance Test

Trial sites (1)

More IRCCS Eugenio Medea trials in Italy

Other trials for the same condition